# Synthesis and Evaluation of Colchicine C-Cyclic AmineDerivatives as Potent Anti-Biofilms Agents AgainstMethicillin-Resistant Staphylococcus aureus

**Authors:** Yuxin Yang, Xin Liu, Can Sun, Yuan Fang, Danyang Qu, Zhengbin Tang, Zetao Sun, Xiaoping Zhou, Dacheng Wang

PMC · DOI: 10.3390/antibiotics14020173 · 2025-02-10

## TL;DR

Scientists designed new colchicine derivatives that can inhibit biofilms of MRSA, a dangerous antibiotic-resistant bacteria.

## Contribution

New colchicine C-ring amine derivatives were synthesized and shown to inhibit MRSA biofilms and affect key biofilm-related genes.

## Key findings

- Most compounds inhibited MRSA biofilm formation with inhibition rates up to 40.79%.
- Compounds 7b–11b showed antibacterial activity or synergistic effects with MICs of 16–32 μg/mL.
- The compounds affect biofilm-related genes icaA and agrA, reducing biofilm formation.

## Abstract

Background/Objectives: The elimination of bacterial biofilm formation is an effective strategy against bacterial infections. The objective was to design 27 colchicine C-ring modified amine derivatives and evaluate their inhibitory activities against the biofilms of MRSA USA300. Methods: Design 27 colchicine C-ring modified amine derivatives. Evaluate their inhibitory activities against MRSA USA300 biofilms. Conduct antibacterial or synergistic antibacterial experiments. Research the phenotypic mechanisms related to biofilm-related genes icaA and agrA. Results: The experiments showed that most compounds in this series exhibited varying degrees of biofilm inhibitory activity (with inhibition rates ranging from 7.72% to 40.79%). Further verification through antibacterial or synergistic antibacterial experiments revealed that the compounds with biofilm-inhibiting effects (compounds 7b–11b) generally had certain antibacterial activities (MICs = 16–32 μg/mL) or synergistic antibacterial effects (FICIs < 0.5). Furthermore, through in-depth research on their phenotypic mechanisms (i.e., research on biofilm-related mechanisms), it was found that the compounds with antibacterial or synergistic antibacterial properties could inhibit the formation of biofilms by affecting the regulation of the biofilm-related genes icaA and agrA. Conclusions: The designed colchicine C-ring modified amine derivatives showed potential in inhibiting MRSA biofilms, and their antibacterial or synergistic antibacterial properties are related to the regulation of biofilm-related genes icaA and agrA, demonstrating inhibitory activity against MRSA.

## Linked entities

- **Genes:** icaA (N-acetylglucosaminyltransferase) [NCBI Gene 11640150], agrA (quorum-sensing response regulator AgrA) [NCBI Gene 3617361]
- **Chemicals:** colchicine (PubChem CID 2833), doxorubicin (PubChem CID 31703)
- **Diseases:** MRSA (MONDO:0100073)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** bacterial infections (MESH:D001424)
- **Chemicals:** Colchicine C-Cyclic AmineDerivatives (-), amine (MESH:D000588)
- **Species:** Staphylococcus aureus (species) [taxon 1280]

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11851440/full.md

---
Source: https://tomesphere.com/paper/PMC11851440